000 | 01948 a2200553 4500 | ||
---|---|---|---|
005 | 20250515011524.0 | ||
264 | 0 | _c20060110 | |
008 | 200601s 0 0 eng d | ||
022 | _a1549-4713 | ||
024 | 7 |
_a10.1016/j.ophtha.2005.10.019 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSlakter, Jason S | |
245 | 0 | 0 |
_aAnecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration. _h[electronic resource] |
260 |
_bOphthalmology _cJan 2006 |
||
300 |
_a3-13 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aChoroidal Neovascularization _xdrug therapy |
650 | 0 | 4 |
_aConnective Tissue _xdrug effects |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFluorescein Angiography |
650 | 0 | 4 | _aFovea Centralis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMacular Degeneration _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPhotochemotherapy |
650 | 0 | 4 |
_aPhotosensitizing Agents _xadverse effects |
650 | 0 | 4 |
_aPorphyrins _xadverse effects |
650 | 0 | 4 |
_aPregnadienediols _xadministration & dosage |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aVerteporfin |
650 | 0 | 4 |
_aVisual Acuity _xphysiology |
700 | 1 | _aBochow, Thomas W | |
700 | 1 | _aD'Amico, Donald J | |
700 | 1 | _aMarks, Bethany | |
700 | 1 | _aJerdan, Janice | |
700 | 1 | _aSullivan, E Kenneth | |
700 | 1 | _aRobertson, Stella M | |
700 | 1 | _aSlakter, Jason S | |
700 | 1 | _aSullins, Greg | |
700 | 1 | _aZilliox, Patricia | |
773 | 0 |
_tOphthalmology _gvol. 113 _gno. 1 _gp. 3-13 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ophtha.2005.10.019 _zAvailable from publisher's website |
999 |
_c15987311 _d15987311 |